␥-aminobutyric acid type A (GABA A ) receptors comprise a subfamily of ligand-gated ion channels whose activity can be modulated by ligands acting at the benzodiazepine binding site on the receptor. The benzodiazepine binding site was characterized using a site-directed mutagenesis strategy in which amino acids of the ␣ 5 subunit were substituted by their corresponding ␣ 1 residues. Given the high affinity and selectivity of ␣ 1 -containing compared with ␣ 5 -containing GABA A receptors for zolpidem, mutated ␣ 5 subunits were co-expressed with  2 and ␥ 2 subunits, and the affinity of recombinant receptors for zolpidem was measured. One ␣ 5 mutant (bearing P162T, E200G, and T204S) exhibited properties similar to that of the ␣ 1 subunit, notably high affinity zolpidem binding and potentiation by zolpidem of GABA-induced chloride current. Two of these mutations, ␣ 5 P162T and ␣ 5 E200G, might alter binding pocket conformation, whereas ␣ 5 T204S probably permits formation of a hydrogen bond with a proton acceptor in zolpidem. These three amino acid substitutions also influenced receptor affinity for CL218872. Our data thus suggest that corresponding amino acids of the ␣ 1 subunit, particularly ␣ 1 -Ser
204, are the crucial residues influencing ligand selectivity at the binding pocket of ␣ 1 -containing receptors, and a model of this binding pocket is presented.